Indonesia's January trade balance recorded a minor surplus of 50 million USD, as compared to market expectation of 241million USD deficit. However, the overall trade activity remains subdued as exports declined 20.7% y/y against market estimate of -15.2%. This improvement in the trade balance comes in as energy trade registered a 114 million USD deficit, while the non-energy trade balance recorded 165million USD surplus.
Commodity exports remained fragile as non-oil and gas shipments declined 16.8% y/y versus its previous print of 13.7% y/y decrease in December. Similarly, imports also fell 17.2% y/y against markets consensus of an 8.7% y/y decline. The import growth is likely to pick up momentum on the back of infrastructure spending, despite slump in January.
The economic conditions are likely to improve in 2016, with initiation of several public infrastructure projects, further aided by government disbursements and additional monetary policy stimulus.
"Bank Indonesia (BI) cut its policy rate 25bp, to 7.25%, in January, and with today's report showing the trade deficit remains under control, we believe the probability of another rate cut from BI this week has risen at the margin" says Barclays in a research note


China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
RBA Raises Interest Rates by 25 Basis Points as Inflation Pressures Persist
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 



